Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun 18;16(1):18579.
doi: 10.7448/IAS.16.1.18579.

Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents

Allison L Agwu  1 , Lee Fairlie
Affiliations
Review

Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents

Allison L Agwu et al. J Int AIDS Soc. .

Abstract

Three decades into the HIV/AIDS epidemic there is a growing cohort of perinatally HIV-infected adolescents globally. Their survival into adolescence and beyond represent one of the major successes in the battle against the disease that has claimed the lives of millions of children. This population is diverse and there are unique issues related to antiretroviral treatment and management. Drawing from the literature and experience, this paper discusses several broad areas related to antiretroviral management, including: 1) diverse presentation of HIV, (2) use of combination antiretroviral therapy including in the setting of co-morbidities and rapid growth and development, (3) challenges of cART, including nonadherence, resistance, and management of the highly treatment-experienced adolescent patient, (4) additional unique concerns and management issues related to PHIV-infected adolescents, including the consequences of longterm inflammation, risk of transmission, and transitions to adult care. In each section, the experience in both resource-rich and limited settings are discussed with the aim of highlighting the differences and importantly the similarities, to share lessons learnt and provide insight into the multi-faceted approaches that may be needed to address the challenges faced by this unique and resilient population.

Keywords: adolescents; combination antiretroviral therapy; management; outcomes; perinatally HIV-infected; resistance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Multi-drug genotypic resistance from a treatment-experienced PHIV-infected adolescent.
See this image and copyright information in PMC

References

    1. UNAIDS. UNAIDS Report on the global AIDS epidemic 2012; 2012. 1-22-0013.
    1. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44. - PMC - PubMed
    1. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access; Geneva, Switzerland: World Health Organization; 2010. Recommendations for a public health approach 2010 version. - PubMed
    1. Hazra R, Siberry GK, Mofenson LM. Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med. 2010;61:169–85. - PubMed
    1. Judd A, Doerholt K, Tookey PA, Sharland M, Riordan A, Menson E, et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996–2006: planning for teenage and adult care. Clin Infect Dis. 2007;45:918–24. - PubMed

Publication types

Substances